Windy City Media Group Frontpage News
Celebrating 30 Years of Gay Lesbian Bisexual and Trans News
home search facebook twitter join
Gay News Sponsor Windy City Times 2018-02-21
DOWNLOAD ISSUE
About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage

Sponsor
Sponsor

  WINDY CITY TIMES

Cook County Health & Hospitals part of study to test new HIV-prevention medication
2016-12-28

facebook twitter google +1 reddit email


Cook County Health & Hospitals System's ( CCHHS ) Ruth M. Rothstein CORE Center is taking part in the first large-scale clinical trial of a long-acting injectable drug for HIV prevention.

The HPTN 083 study will evaluate whether an investigational anti-HIV drug called cabotegravir, which can be taken once every 8 weeks, can safely protect men and transgender women from HIV infection as well as the anti-HIV medication Truvada. Truvada—consisting of two anti-HIV drugs emtricitabine and tenofovir disoproxil fumarate—must be taken once a day to be effective, and it has been shown to reduce the risk of HIV infection in people who are at high risk by up to 92 percent.

Dr. Temitope Oyedele, who is the lead investigator for the study at the CORE Center, said Truvada "has been shown to be effective as pre-exposure prophylaxis against HIV, but the biggest problem is that a lot of people don't remember to take it every day."

"What makes this study so important is it could provide a viable alternative where patients won't have to take a pill every day, but could instead get an injection once every two months and be protected," said Dr. Oyedele, an Attending Physician in the Division of Infectious Diseases at CCHHS' John H. Stroger Jr., Hospital.

HPTN 083 will enroll approximately 4,500 HIV-uninfected men or transgender women who have sex with men at 45 sites in eight countries, including the U.S. and countries in Africa, Asia and South America. Participants must be 18 years or older to participate in the study and be at high risk of getting HIV.

The study will last up to 4.5 years, and participants will be transitioned to locally available HIV prevention services when their participation in the study ends.

The study is sponsored by the National Institutes of Health. ViiV Healthcare and Gilead Sciences ( the manufacturers of cabotegravir and Truvada respectively ) are providing the study medications.

For more information about HPTN 083, visit ClinicalTrials.gov using study identifier NCT02720094.

Contact the CORE Center to learn more about taking part in the trial by calling ( 312 ) 869-4289.


facebook twitter google +1 reddit email




Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.


  ARTICLES YOU MIGHT LIKE

Gay News

Advocates: Transmission laws hinder HIV/AIDS prevention efforts 2018-02-20 - Laws that penalize intimate partner contact wherein one person has failed to inform the other that they are HIV-positive are viewed by many ...


Gay News

Black LGBTQA event 'Recognitions' Feb. 23 2018-02-20 - The Chicago Department of Public Health and the Chicago Black Gay Men's Caucus are hosting "The Chicago LGBTQA Black History Recognitions" on Friday, ...


Gay News

HIV-criminalization panel Feb. 15 2018-02-14 - Legal Health Council for Justice and TPAN will co-host "HIV Criminalization: Beyond Shame and Stigma" on Thursday, Feb. 15, at Center on Halsted, ...


Gay News

WORLD NEWS Costa Rica election, PrEP news, HIV outbreak 2018-02-13 - New Zealand has announced that it will publicly fund PrEP ( pre-exposure prophylaxis ) for just $1.20 a month for a prescription, PinkNews ...


Gay News

Planned Parenthood airs HIV prevention videos on National Black HIV/AIDS Awareness Day 2018-02-08 - Washington, D.C. — On National Black HIV/AIDS Awareness Day, Planned Parenthood Federation of America is launching new educational videos on pre-exposure prophylaxis ( ...


Gay News

Planned Parenthood launches youth-led campaign about birth control, sexual health 2018-02-08 - ( Chicago ) - Planned Parenthood of Illinois ( PPIL ) has launched My Body. My Story.- a youth-led campaign designed to increase ...


Gay News

Emanuel announces 'Getting to Zero' investments 2018-02-07 - Mayor Rahm Emanuel and the Chicago Department of Public Health ( CDPH ) announced $36 million in new HIV funding opportunities to support ...


Gay News

SSHC to provide 'Panther' tickets with HIV testing 2018-02-06 - Via a ticket giveaway, South Side Help Center ( SSHC ) is promoting HIV/AIDS prevention and care specifically targeting the African-American community in ...


Gay News

Publix decides to add PrEP coverage for employees, HRC responds 2018-02-06 - Publix has announced via Twitter that they are in the process of reversing course on PrEP: "Publix appreciates the concerns shared by our ...


Gay News

HUD assists HIV/AIDS groups with $4.1M 2018-01-30 - The U.S. Department of Housing and Urban Development ( HUD ) announced $4.1 million for three groups to assist low-income persons living with ...


 



Copyright © 2018 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 

TRENDINGBREAKINGPHOTOS

Sponsor
Sponsor
Sponsor


 



Sponsor

About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Subscriptions      Distribution      Windy City Queercast     
Queercast Archives      Advertising  Rates      Deadlines      Advanced Search     
Press  Releases      Event Photos      Join WCMG  Email List      Email Blast     
Upcoming Events      Todays Events      Ongoing Events      Post an Event      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Blogs      Spotlight  Video     
Classifieds      Real Estate      Place a  Classified     

Windy City Media Group produces Windy City Queercast, & publishes Windy City Times,
The Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community,
Nightspots, Out! Resource Guide, and Identity.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.